Standard Glass Lining Technology Limited announced its results for the second quarter of FY26, marking another significant ...
Late Phase (USD 338.4B – USD 501.9B): Startups and technology-driven companies capture significant demand in emerging regions ...
In a significant move highlighting confidence in an innovative biotechnology platform, Renaissance Group LLC has established ...
Hilliard, the HHS spokesperson, told SFGATE on Tuesday that, “Secretary [Robert F.] Kennedy [Jr.] expects the highest ethical ...
Mukteshwar, Nainital, has become the epicentre of global and national scientific collaboration this week as it hosts two ...
CollaBraid is the first product the company aims to bring to market in 2026. The technology is a hybrid collagen suture — a thread-like material that surgeons use to stitch tissue together — for a ...
Forbion BioEconomy Fund I reaches hard cap, following its first close in 2024.The Fund's planetary health mandate leverages ...
China's Angel Yeast has begun operating an 11,000-tonne production line for its yeast protein, bolstering the country's ...
The Nation has won overall best at the Ninth Open Forum on Agricultural Biotechnology (OFAB) Nigeria Media Awards. The ...
Dr Srishti Mathur created this diabetic-friendly alternative by converting Brewer’s Spent Grain (BSG), the primary by-product ...
"It offers huge potential to boost food security, cut pesticide use, increase crop yields and enhance disease resistance and we are backing it with a multimillion-pound investment," the Department for ...
A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results